Clinical Trial: Mepolizumab Pharmacokinetics Among Patients With Severe Asthma
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Asthma
Study Type: INTERVENTIONAL
Official Title: Mepolizumab Pharmacokinetics Among Patients With Severe Asthma: Protocol for a Case Control Study Comparing Clinical Responders Versus Non Responders
Brief Summary:
Asthma is a chronic disease characterized by inflammation and obstruction of the airways.Identification of the mechanisms of action of corticosteroids has made it possible to define the type 2 inflammation present in nearly 80% of patients with asthma.Monoclonal antibodies (MAb) in severe asthma target type-2 inflammation.Mepolizumab is a humanized IgG1 (immunoglobulin gamma-1) kappa subclass monoclonal antibody directed specifically against interleukin 5 (IL-5).It acts specifically on eosinophil homeostasis, with…
Read more